Zenotech Laboratories Limited: New company profile publishedZenotech Laboratories Limited (Zenotech), develops and manufactures generic biopharmaceuticals. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The company's Generic biopharmaceuticals is ... TransWorldNews, 1 month ago |
Biosimilar Drug Revenues Will Reach $2,445m Worldwide in 2013, Predicts New visiongain ReportA new report by visiongain predicts the world market for biosimilar drugs will be worth $2,445m in 2013, growing by more than 20% from 2012. In 2013 it will account for around 2% of the overall biologics (biological drugs) market. That study ... ADVFN India, 1 week ago
|
Andhra Pradesh: From bulk drugs to affordable medicines, vaccines"In Hyderabad, entrepreneurs are driven by a herd mentality. If there is one successful venture, a dozen will follow. The high number of bulk drug manufacturers in a way is just manifestation of such a trend". Habil Khorakiwala, Chairman of ... Hindu Business Line, 3 weeks ago
|
Competitor Analysis: G-CSF and GM-CSFhe present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets and products in non-regulated markets, ... Research and Markets, 3 weeks ago
Competitor Analysis: Antibody Therapy of Inflammatory and Autoimmune Diseases
PipelineReview, 1 month ago
|
Age Related Macular Degeneration - Pipeline Review, H1 2013Age Related Macular Degeneration Pipeline Review, H1 2013 Summary Global Markets Direct's, ' ', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Age Related Macular ... Research and Markets, 1 month ago
Breast Cancer - Pipeline Review, H1 2013
Research and Markets, 1 month ago
Rheumatoid Arthritis - Pipeline Review, H1 2013
Research and Markets, 1 month ago
Multiple Sclerosis - Pipeline Review, H1 2013
Research and Markets, 1 month ago
|
Next-Generation Antibody Therapeutics Market 2013-2023/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: ... TickerTech.com, 1 month ago
|
Competitor Analysis: VEGF Antibodies - Bevacizumab and Ranibizumab Biosimilars and BiosuperiorsResearch and Markets (http://www.researchandmarkets.com/research/whsrrt/competitor) has announced the addition of the "" report to their offering. The present Competitive Intelligence Report about VEGF Antibodies - Bevacizumab and Ranibizumab ... Individual.com, 1 month ago
Research and Markets: Competitor Analysis: VEGF Antibodies - Bevacizumab and Ranibizumab Biosimilars and Biosuperiors
TMC Net, 1 month ago
More from: , Reuters...and 2 other sources
|